Informações:
Falhas:
ID
30155
Descrição
Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00824265
Link
https://clinicaltrials.gov/show/NCT00824265
Palavras-chave
Versões (1)
- 16/05/2018 16/05/2018 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
16 de maio de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Leukaemia, Lymphocytic, Chronic NCT00824265
Eligibility Leukaemia, Lymphocytic, Chronic NCT00824265
- StudyEvent: Eligibility
Similar models
Eligibility Leukaemia, Lymphocytic, Chronic NCT00824265
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Chronic Lymphocytic Leukemia Treatment required for
Item
confirmed and active cll requiring treatment
boolean
C0023434 (UMLS CUI [1,1])
C0332121 (UMLS CUI [1,2])
C0332121 (UMLS CUI [1,2])
Prior Therapy Quantity Chronic Lymphocytic Leukemia | Complete remission | Partial response | Disease Progression
Item
at least one previous treatment for cll and having achieved a complete or partial remission/response but after a period of 6 or more months, shows evidence of disease progression
boolean
C1514463 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0023434 (UMLS CUI [1,3])
C0677874 (UMLS CUI [2])
C1521726 (UMLS CUI [3])
C0242656 (UMLS CUI [4])
C1265611 (UMLS CUI [1,2])
C0023434 (UMLS CUI [1,3])
C0677874 (UMLS CUI [2])
C1521726 (UMLS CUI [3])
C0242656 (UMLS CUI [4])
Other Coding | Self-care Capability | Fit and well Percentage
Item
fully active at a minimum or fully capable of selfcare and up and about more than 50% of waking hours
boolean
C3846158 (UMLS CUI [1])
C0036592 (UMLS CUI [2,1])
C2698977 (UMLS CUI [2,2])
C0424576 (UMLS CUI [3,1])
C0439165 (UMLS CUI [3,2])
C0036592 (UMLS CUI [2,1])
C2698977 (UMLS CUI [2,2])
C0424576 (UMLS CUI [3,1])
C0439165 (UMLS CUI [3,2])
Age
Item
age 18yrs or older
boolean
C0001779 (UMLS CUI [1])
Informed Consent
Item
signed written informed consent
boolean
C0021430 (UMLS CUI [1])
Chronic lymphocytic leukaemia refractory | Complete remission failed | Partial response failed | Disease Progression
Item
diagnosis of refractory cll (failure to achieve a complete or partial remission/response or disease progression within 6 months of last anti-cll treatment
boolean
C0278791 (UMLS CUI [1])
C0677874 (UMLS CUI [2,1])
C0231175 (UMLS CUI [2,2])
C1521726 (UMLS CUI [3,1])
C0231175 (UMLS CUI [3,2])
C0242656 (UMLS CUI [4])
C0677874 (UMLS CUI [2,1])
C0231175 (UMLS CUI [2,2])
C1521726 (UMLS CUI [3,1])
C0231175 (UMLS CUI [3,2])
C0242656 (UMLS CUI [4])
ABNORMAL LABORATORY RESULT (HEMATOLOGY) | Liver Dysfunction | Abnormal renal function
Item
abnormal/inadequate blood values, liver and kidney function
boolean
C0262364 (UMLS CUI [1])
C0086565 (UMLS CUI [2])
C0151746 (UMLS CUI [3])
C0086565 (UMLS CUI [2])
C0151746 (UMLS CUI [3])
Heart problems | Disease Serious | Autoimmune hemolytic anemia | Cancer Other
Item
certain heart problems, serious significant diseases, aiha, other current cancers or within the last 5 years
boolean
C0795691 (UMLS CUI [1])
C0012634 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C0002880 (UMLS CUI [3])
C1707251 (UMLS CUI [4])
C0012634 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C0002880 (UMLS CUI [3])
C1707251 (UMLS CUI [4])
Communicable Diseases | Chronic infectious disease
Item
active or chronic infections
boolean
C0009450 (UMLS CUI [1])
C0151317 (UMLS CUI [2])
C0151317 (UMLS CUI [2])
Anti-Allergic Agents | Anti-Inflammatory Agents | Glucocorticoids
Item
use of drugs to suppress allergic or inflammatory responses (glucocorticoids)
boolean
C0282555 (UMLS CUI [1])
C0003209 (UMLS CUI [2])
C0017710 (UMLS CUI [3])
C0003209 (UMLS CUI [2])
C0017710 (UMLS CUI [3])
Chronic lymphocytic leukaemia transformation
Item
cll transformation
boolean
C1142081 (UMLS CUI [1])
Chronic Lymphocytic Leukemia | Central Nervous System Involvement
Item
cll central nervous system involvement
boolean
C0023434 (UMLS CUI [1])
C4050309 (UMLS CUI [2])
C4050309 (UMLS CUI [2])
Study Subject Participation Status
Item
current participation in other clinical study
boolean
C2348568 (UMLS CUI [1])
Protocol Compliance Unable
Item
inability to comply with the protocol activities
boolean
C0525058 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,2])
Breast Feeding | Pregnancy | Childbearing Potential Contraceptive methods Unwilling | Gender Partner in relationship Childbearing Potential
Item
lactating or pregnant women or female patients of child-bearing potential (or male patients with such partners) not willing to use adequate contraception
boolean
C0006147 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
C3831118 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
C0558080 (UMLS CUI [3,3])
C0079399 (UMLS CUI [4,1])
C0682323 (UMLS CUI [4,2])
C3831118 (UMLS CUI [4,3])
C0032961 (UMLS CUI [2])
C3831118 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
C0558080 (UMLS CUI [3,3])
C0079399 (UMLS CUI [4,1])
C0682323 (UMLS CUI [4,2])
C3831118 (UMLS CUI [4,3])